Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nimotuzumab in Children With HGG

This study has been completed.
Sponsor:
Collaborators:
Children`s Medical Hospital, University of Bonn, Germany
University of Wuerzburg
University of Bonn
Dept. of Statistics, University of Dortmund, Germany
CRM Biometrics GmbH
Heinrich-Heine University, Duesseldorf
Klinikum Augsburg
Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany
Children`s Medical Hospital, University of Homburg/Saar, Homburg/Saar, Germany
Hannover Medical School
Children's Medical Hospital, University of Essen, Essen, Germany
Dept. of Neuropediatrics and Muscle Disorders, University of Freiburg, Germany
University of Cologne
Universitätsklinikum Hamburg-Eppendorf
University of Regensburg
Information provided by:
Oncoscience AG
ClinicalTrials.gov Identifier:
NCT00561873
First received: November 20, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Estimated Primary Completion Date: No date given